In addition, whereas FAK was found associated with poor outcome in AML [19,20,21], no studies have addressed SRC, PYK2 or LYN expression as possible prognostic factors in AML, and particularly in IR-AML patients. This evidence concerns the gene PTK2 and acute myeloid leukemia.